Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches

In recent years, medication-related osteonecrosis of the jaw (MRONJ) became an arising disease due to the important antiresorptive drug prescriptions to treat oncologic and osteoporotic patients, as well as the use of new antiangiogenic drugs such as VEGF antagonist. So far, MRONJ physiopathogenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombard, Thomas, Neirinckx, Virginie, Rogister, Bernard, Gilon, Yves, Wislet, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046039/
https://www.ncbi.nlm.nih.gov/pubmed/27721837
http://dx.doi.org/10.1155/2016/8768162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046039/
https://www.ncbi.nlm.nih.gov/pubmed/27721837
http://dx.doi.org/10.1155/2016/8768162

Ejemplares similares